High-Priced Drugs in Medicare Part D: Diagnosis and Potential Prescription

Richard G. Frank and Richard J. Zeckhauser investigate High-Priced Drugs in Medicare Part D: Diagnosis and Potential Prescription. ABSTRACT: Drug pricing in the U.S. is a persistently vexing policy problem. While there is agreement among many policy analysts that supra…

Read more detail on Recent Antitrust posts –

This entry was posted in Antitrust - Competition law and tagged , , , , , , . Bookmark the permalink.

Leave a Reply